Wan and colleagues [29] recently discovered that KLF4 interacts with methylated DNA to activate RhoC expression via chromatin remodeling, in turn promoting GBM adhesion and migration, two hallmark tumor characteristics that make combatting GBM difficult. The gene discussed is KLF4; the disease is neoplasm.